ALKEMNSEAlkem Laboratories Limited· Pharmaceuticals & BiotechnologyHighNegative
Announced Thu, 4 Dec, 2025 · 13:39 IST

Alkem Labs receives GST demand order of about Rs 54.94 lakh from Dehradun authorities

ALKEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.2%Reaction day
₹5648.00
prior close
₹5669.50
announcement price
In-mkt
timing
Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)-0.0%-0.1% vs market
Pharmaceuticals peers, median of 156sector-0.2%+0.0% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Midcap 150 and in line with its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.0
10m
-0.1
15m
-0.1
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.2-0.0-0.1-0.2+0.0
Next day
+0.7+0.4+0.3-0.5+1.2
2d
-0.9-1.4+0.4-2.6+1.7
3d
+0.4-1.0+1.4-1.9+2.3
4d
-1.2-1.9+0.7-2.0+0.8
5d
-0.5-1.1+0.5-1.2+0.7
1w
-0.7+0.0-0.7-0.7+0.1
15d
-2.0+0.3-2.2-1.3-0.7
1m
-1.4+1.9-3.3-0.3-1.1
2m
+0.2-0.6+0.8-5.6+5.8
3m
-3.3-5.1+1.8-10.4+7.0
UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Alkem Laboratories received a GST order from the Assistant Commissioner, Central GST Division, Dehradun covering FY 2018-19 to 2022-23. The order demands GST of Rs 27.14 lakh, penalty of Rs 27.79 lakh, plus applicable interest, alleging excess availment of Input Tax Credit. The company disagrees with the demand and plans to file an appeal. Alkem states there is no material impact on its financials or operations.

Likely market impact

Minor tax dispute, company says no material impact. Appeal planned. Watch for any further escalation in future filings.